Your browser doesn't support javascript.
loading
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes.
Alanio, Cécile; Binder, Zev A; Chang, Renee B; Nasrallah, MacLean P; Delman, Devora; Li, Joey H; Tang, Oliver Y; Zhang, Logan Y; Zhang, Jiasi Vicky; Wherry, E John; O'Rourke, Donald M; Beatty, Gregory L.
Affiliation
  • Alanio C; INSERM U932, PSL University, Institut Curie, Paris, France.
  • Binder ZA; Laboratoire d'immunologie clinique, Institut Curie, Paris, France.
  • Chang RB; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Nasrallah MP; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Delman D; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, Pennsylvania.
  • Li JH; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Tang OY; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zhang LY; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zhang JV; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Wherry EJ; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • O'Rourke DM; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Beatty GL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Cancer Immunol Res ; 10(7): 800-810, 2022 07 01.
Article in En | MEDLINE | ID: mdl-35507919
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Immunol Res Year: 2022 Document type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Immunol Res Year: 2022 Document type: Article Affiliation country: France